{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:55:00Z","timestamp":1794473700528,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00415-026-13638-y","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T15:55:44Z","timestamp":1769788544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospective observational study of magnetic resonance imaging in anti-CD19 CAR T-cell-associated neurotoxicity"],"prefix":"10.1007","volume":"273","author":[{"given":"Gian Maria","family":"Asioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pondrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Spinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Vornetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Maffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"13638_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112312","author":"M Elmarasi","year":"2024","unstructured":"Elmarasi M, Elkonaissi I, Elsabagh AA et al (2024) CAR-T cell therapy: efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2024.112312","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"13638_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25(4):625\u2013638. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"13638_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41584-024-01139-z","volume":"20","author":"G Schett","year":"2024","unstructured":"Schett G, M\u00fcller F, Taubmann J et al (2024) Advancements and challenges in CAR T cell therapy in autoimmune diseases. Nat Rev Rheumatol 20(9):531\u2013544. https:\/\/doi.org\/10.1038\/s41584-024-01139-z","journal-title":"Nat Rev Rheumatol"},{"key":"13638_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","volume":"8","author":"BD Santomasso","year":"2018","unstructured":"Santomasso BD, Park JH, Salloum D et al (2018) Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia. Cancer Discov 8:958\u2013971. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1319","journal-title":"Cancer Discov"},{"issue":"8","key":"13638_CR5","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1007\/s00415-022-11117-8","volume":"269","author":"U Pensato","year":"2022","unstructured":"Pensato U, Muccioli L, Zinzani P et al (2022) Fulminant cerebral oedema following CAR T-cell therapy: case report and pathophysiological insights from literature review. J Neurol 269(8):4560\u20134563. https:\/\/doi.org\/10.1007\/s00415-022-11117-8","journal-title":"J Neurol"},{"issue":"6","key":"13638_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jtct.2022.03.006","volume":"28","author":"SJ Grant","year":"2022","unstructured":"Grant SJ, Grimshaw AA, Silberstein J et al (2022) Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review. Transplant Cell Ther 28(6):294\u2013302. https:\/\/doi.org\/10.1016\/j.jtct.2022.03.006","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"13638_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/bjh.19270","volume":"204","author":"GM Asioli","year":"2024","unstructured":"Asioli GM, Castioni CA, Zinzani PL et al (2024) Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: not all is lost! Br J Haematol 204(3):1109\u20131113. https:\/\/doi.org\/10.1111\/bjh.19270","journal-title":"Br J Haematol"},{"key":"13638_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1392831","volume":"15","author":"MW Han","year":"2024","unstructured":"Han MW, Jeong SY, Suh CH et al (2024) Incidence of immune effector cell-associated neurotoxicity among patients treated with CAR T-cell therapy for hematologic malignancies: systematic review and meta-analysis. Front Neurol 15:1392831. https:\/\/doi.org\/10.3389\/fneur.2024.1392831","journal-title":"Front Neurol"},{"key":"13638_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577027","volume":"11","author":"J Gust","year":"2020","unstructured":"Gust J, Ponce R, Liles WC, Garden GA, Turtle CJ (2020) Cytokines in CAR T cell-associated neurotoxicity. Front Immunol 11:577027. https:\/\/doi.org\/10.3389\/fimmu.2020.577027","journal-title":"Front Immunol"},{"issue":"5","key":"13638_CR10","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s00415-023-11595-4","volume":"270","author":"U Pensato","year":"2023","unstructured":"Pensato U, Amore G, Muccioli L et al (2023) CAR t-cell therapy in BOlogNa-NEUrotoxicityTReatment and Assessment in Lymphoma (CARBON-NEUTRAL): proposed protocol and results from an Italian study. J Neurol 270(5):2659\u20132673. https:\/\/doi.org\/10.1007\/s00415-023-11595-4","journal-title":"J Neurol"},{"issue":"6","key":"13638_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1576","volume":"14","author":"T Gu","year":"2022","unstructured":"Gu T, Hu K, Si X et al (2022) Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment. WIREs Mech Dis 14(6):e1576. https:\/\/doi.org\/10.1002\/wsbm.1576","journal-title":"WIREs Mech Dis"},{"issue":"5","key":"13638_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13102-3","volume":"272","author":"F Pondrelli","year":"2025","unstructured":"Pondrelli F, Muccioli L, Mason F et al (2025) EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy. J Neurol 272(5):360. https:\/\/doi.org\/10.1007\/s00415-025-13102-3","journal-title":"J Neurol"},{"issue":"3","key":"13638_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2022","unstructured":"Hayden PJ, Roddie C, Bader P et al (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol 33(3):259\u2013275. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.003","journal-title":"Ann Oncol"},{"issue":"10","key":"13638_CR14","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1080\/10428194.2022.2074990","volume":"63","author":"AH Lapidus","year":"2022","unstructured":"Lapidus AH, Anderson MA, Harrison SJ et al (2022) Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Leuk Lymphoma 63(10):2364\u20132374. https:\/\/doi.org\/10.1080\/10428194.2022.2074990","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"13638_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/jon.13138","volume":"33","author":"SN Pinto","year":"2023","unstructured":"Pinto SN, Liu CJ, Nelson MD Jr et al (2023) Neuroimaging of complications arising after CD19 chimeric antigen receptor T-cell therapy: a review. J Neuroimaging 33(5):703\u2013715. https:\/\/doi.org\/10.1111\/jon.13138","journal-title":"J Neuroimaging"},{"issue":"12","key":"13638_CR16","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","volume":"7","author":"J Gust","year":"2017","unstructured":"Gust J, Hay KA, Hanafi LA et al (2017) Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov 7(12):1404\u20131419. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0698","journal-title":"Cancer Discov"},{"key":"13638_CR17","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1182\/bloodadvances.2020002228","volume":"4","author":"P Strati","year":"2020","unstructured":"Strati P, Nastoupil LJ, Westin J et al (2020) Clinical and radiologic correlatesof neurotoxicity after axicabtagene ciloleucel in large B-celllymphoma. Blood Adv 4:3943\u20133951","journal-title":"Blood Adv"},{"issue":"9","key":"13638_CR18","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1007\/s00330-025-11515-2","volume":"35","author":"HG Kim","year":"2025","unstructured":"Kim HG, Yeom KW, Vasyliv I et al (2025) Brain MRI changes in children and young adults with B-cell acute lymphoblastic leukemia following chimeric antigen receptor T-cell therapy. Eur Radiol 35(9):5206\u20135216. https:\/\/doi.org\/10.1007\/s00330-025-11515-2","journal-title":"Eur Radiol"},{"key":"13638_CR19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214086","volume":"7","author":"JL McGuire","year":"2025","unstructured":"McGuire JL, Pinto S, Erdogan EN et al (2025) Neuroimaging findings in children and young adults with neurotoxicity after CAR T-cell therapy for B-cell malignancies. Neurology 7:e214086. https:\/\/doi.org\/10.1212\/WNL.0000000000214086","journal-title":"Neurology"},{"issue":"2","key":"13638_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00415-021-10766-5","volume":"269","author":"U Pensato","year":"2022","unstructured":"Pensato U, Amore G, D\u2019Angelo R et al (2022) Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity. J Neurol 269(2):609\u2013615. https:\/\/doi.org\/10.1007\/s00415-021-10766-5","journal-title":"J Neurol"},{"issue":"8","key":"13638_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714\u2013725. https:\/\/doi.org\/10.1016\/S1474-4422(22)00208-3","journal-title":"Lancet Neurol"},{"issue":"4","key":"13638_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200488","volume":"15","author":"A Vichare","year":"2025","unstructured":"Vichare A, Lee JS, Duong TQ (2025) Neuroimaging findings of CAR T-cell-associated neurotoxicity: a review. Neurol Clin Pract 15(4):e200488. https:\/\/doi.org\/10.1212\/CPJ.0000000000200488","journal-title":"Neurol Clin Pract"},{"issue":"20","key":"13638_CR23","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1182\/blood.2022017604","volume":"141","author":"BD Santomasso","year":"2023","unstructured":"Santomasso BD, Gust J, Perna F (2023) How i treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity. Blood 141(20):2443\u20132451. https:\/\/doi.org\/10.1182\/blood.2022017604","journal-title":"Blood"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13638-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13638-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13638-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:04:04Z","timestamp":1773785044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13638-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13638"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13638-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by our institutional review board, Ethical Committee AVEC of Bologna (protocol number: CE: 319\/2021\/Sper\/AOUBo).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"109"}}